Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
OGI logo OGI
Upturn stock ratingUpturn stock rating
OGI logo

OrganiGram Holdings Inc (OGI)

Upturn stock ratingUpturn stock rating
$1.04
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

04/01/2025: OGI (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -62.9%
Avg. Invested days 22
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 04/01/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 141.50M USD
Price to earnings Ratio -
1Y Target Price 8.8
Price to earnings Ratio -
1Y Target Price 8.8
Volume (30-day avg) 849301
Beta 1.04
52 Weeks Range 0.96 - 2.37
Updated Date 04/1/2025
52 Weeks Range 0.96 - 2.37
Updated Date 04/1/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.34

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -31.69%
Operating Margin (TTM) -15.92%

Management Effectiveness

Return on Assets (TTM) -5.56%
Return on Equity (TTM) -54.53%

Valuation

Trailing PE -
Forward PE 28.99
Enterprise Value 112594400
Price to Sales(TTM) 0.85
Enterprise Value 112594400
Price to Sales(TTM) 0.85
Enterprise Value to Revenue 0.97
Enterprise Value to EBITDA 9.27
Shares Outstanding 133779000
Shares Floating 88129783
Shares Outstanding 133779000
Shares Floating 88129783
Percent Insiders 34.41
Percent Institutions 6.48

Analyst Ratings

Rating 4.33
Target Price 8.8
Buy -
Strong Buy 4
Buy -
Strong Buy 4
Hold 2
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

OrganiGram Holdings Inc

stock logo

Company Overview

History and Background

OrganiGram Holdings Inc. was founded in 2013 in Moncton, New Brunswick, Canada. It initially focused on medical cannabis production and has since expanded into the recreational market after legalization in Canada. A significant milestone was becoming one of the first licensed producers in Canada. The company has evolved through strategic acquisitions and expansions into new product categories.

Core Business Areas

  • Cannabis Production: Cultivation, processing, and sale of cannabis flower, pre-rolls, edibles, vaporizers, and concentrates for both medical and recreational markets.
  • International Expansion: Developing and executing strategies for international market penetration, including partnerships and export agreements.
  • Product Innovation: Research and development of new cannabis products and formulations to meet evolving consumer demands.

Leadership and Structure

The leadership team comprises a CEO, CFO, COO, and other key executives responsible for overseeing the company's operations, strategic direction, and financial performance. The organizational structure is hierarchical, with departments responsible for cultivation, processing, sales, marketing, and research and development.

Top Products and Market Share

Key Offerings

  • SHRED: SHRED is a popular milled flower product known for its convenience and affordability. It competes with other milled flower products from companies like Aurora Cannabis and Canopy Growth. Market share data is not publicly available but SHRED is a large contributor to OrganiGram's revenue.
  • Edison Cannabis Co.: Edison is a premium cannabis brand offering a range of flower, pre-rolls, and concentrates. Competitors include premium brands from Canopy Growth and Aphria. Market share data is not publicly available.
  • Trailblazer: Trailblazer is a value-focused brand offering a variety of cannabis products at accessible price points. Competitors include value brands from other Canadian LPs. Market share data is not publicly available.

Market Dynamics

Industry Overview

The cannabis industry is characterized by rapid growth, evolving regulations, and increasing competition. Key trends include product innovation, consolidation, and international expansion. The Canadian market is mature with significant regulatory hurdles and competition. Legalization is expanding in other countries offering global opportunities.

Positioning

OrganiGram is positioned as a leading Canadian cannabis producer with a focus on product innovation and efficient production. Its competitive advantages include its indoor cultivation facility and focus on value-added products.

Total Addressable Market (TAM)

The global cannabis market is projected to reach hundreds of billions of dollars in the coming years. OrganiGram is positioned to capture a portion of this market through its diversified product portfolio and international expansion efforts.

Upturn SWOT Analysis

Strengths

  • Indoor cultivation facility for consistent product quality
  • Focus on value-added products like edibles and concentrates
  • Strategic partnerships for international expansion
  • Strong brand recognition in the Canadian market

Weaknesses

  • Limited presence in international markets compared to peers
  • Dependence on the Canadian market
  • Profitability challenges in a competitive market
  • Historical inventory write-downs

Opportunities

  • Expansion into new international markets
  • Increased focus on cannabis 2.0 products (edibles, beverages, etc.)
  • Strategic acquisitions to expand product portfolio
  • Continued product innovation and development

Threats

  • Intense competition from other cannabis producers
  • Evolving regulations and compliance requirements
  • Price compression in the Canadian market
  • Fluctuations in cannabis demand

Competitors and Market Share

Key Competitors

  • ACB
  • CGC
  • TLRY
  • CRON

Competitive Landscape

OrganiGram faces intense competition from larger cannabis producers. Its strengths lie in its indoor cultivation and focus on innovative products. Weaknesses include its limited international presence compared to its competitors.

Major Acquisitions

Laurentian Organic Inc.

  • Year: 2024
  • Acquisition Price (USD millions): 26
  • Strategic Rationale: Strategic reasons: To expand portfolio, scale and manufacturing of hash and other premium products.

Growth Trajectory and Initiatives

Historical Growth: Historical growth trends cannot be provided without real-time access to market sources.

Future Projections: Future growth projections cannot be provided without real-time access to market sources.

Recent Initiatives: Recent initiatives include international expansion, product innovation, and strategic partnerships to drive growth.

Summary

OrganiGram is a Canadian cannabis producer focusing on innovative products and efficient production. It faces competition from larger players and profitability challenges in the mature Canadian market. International expansion and continued product innovation are key to future growth. Recent acquistions such as Laurentian Organic show promise for future growth.

Similar Companies

  • ACB
  • CGC
  • TLRY
  • CRON
  • HEXO

Sources and Disclaimers

Data Sources:

  • Company filings
  • Industry reports
  • Analyst estimates

Disclaimers:

The data provided is for informational purposes only and should not be considered financial advice. Market data is dynamic and subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About OrganiGram Holdings Inc

Exchange NASDAQ
Headquaters Toronto, ON, Canada
IPO Launch date 2014-08-27
CEO & Director Ms. Beena G. Goldenberg
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 1093
Full time employees 1093

Organigram Holdings Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. The company is headquartered in Toronto, Canada.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​